SilcsBio provides software and services for unlocking the full potential of computer-driven drug design. SilcsBio's algorithms for mapping proteins provide a level of detail never before experienced. From its highly accurate free energy maps to conformational nuances revealing hidden pockets of opportunity, SilcsBio offers commercial software and services based on their software for structure-based drug design and has customers in the US, UK, Japan, and Europe.